mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.4 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |